| Symbol | TSX : AMB |
|---|---|
| Last trade | 0.15 |
| Volume | 120,450 |
| As of | 2008-08-19 15:59 EST |
| Note: Quotes are delayed. For informational purposes only. |
|
Conference calls and webcasts
- August 14, 2008
- Canaccord Adams 28th Annual Global Growth Conference
- August 11, 2008
- Second quarter 2008 results
- June 10, 2008
- Annual General Meeting of Shareholders
- May 14, 2008
- C2L Phase III 24-week Results and First Quarter 2008 Financial Results
- March 25, 2008
- Fiscal 2007 Results and Review of Programs and Milestones
- February 12, 2008
- BIO CEO & Investor 2008 Conference Presentation
- January 22, 2008
- Octreotide Phase III preliminary results
- November 14, 2007
- Third Quarter 2007 Results
- August 10, 2007
- Second Quarter 2007 Results
- June 14, 2007
- Annual General and Special Meeting of Shareholders
- May 10, 2007
- First Quarter 2007 Results
- April 24, 2007
- PCK3145 Phase I/II Study Findings
- March 28, 2007
- Fiscal year 2006 results
- March 13, 2007
- Ambrilia and Mallinckrodt announce IND filing (Octreotide)
- November 14, 2006
- Third Quarter results
- October 12, 2006
- Ambrilia and Merck & Co. sign a licensing agreement
- September 25, 2006
- UBS Global Life Sciences Conference
- August 10, 2006
- Second quarter 2006 results
- June 20, 2006
- Annual General Meeting of Shareholders 2005
- May 10, 2006
- First Quarter 2006 Results
- February 24, 2006
- Special Shareholders Meeting - Procyon Biopharma
- January 19, 2006
- Procyon and Cellpep to merge via acquisition
- December 31, 1969
- Second quarter 2008 results
